Your browser doesn't support javascript.
loading
Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.
Liew, Phui-Ly; Huang, Rui-Lan; Weng, Yu-Chun; Fang, Chia-Lang; Hui-Ming Huang, Tim; Lai, Hung-Cheng.
Afiliação
  • Liew PL; Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Huang RL; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Weng YC; Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Fang CL; Translational epigenetic center, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Hui-Ming Huang T; Translational epigenetic center, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Lai HC; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Int J Cancer ; 143(2): 355-367, 2018 07 15.
Article em En | MEDLINE | ID: mdl-29451304

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias Ovarianas / Adenocarcinoma Mucinoso / Metilação de DNA / Complexo de Endopeptidases do Proteassoma / Inibidores de Proteassoma Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias Ovarianas / Adenocarcinoma Mucinoso / Metilação de DNA / Complexo de Endopeptidases do Proteassoma / Inibidores de Proteassoma Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article